arrow
M

Markos Papakonstantis

wroclaw university of science & technology
H指数:6
被引数:90

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Vilobelimab to improve clinical outcomes in moderate-to-severe hidradenitis suppurativa through an adjunctive effect on draining tunnels: results of the SHINE double-blind placebo-controlled randomized trial

Vilobelimab通过在引流隧道上的附加作用改善中重度化脓性汗腺炎的临床结局:SHINE双盲、安慰剂对照随机试验结果

2025-11-011
OAAI
Epidemiology and management of pemphigus in Greece: A 5-year, multicentre study

希腊天疱疮的流行病学和管理:一项为期5年的多中心研究

2025-08-230
PRE
Multidimensional Burden of Moderate-to-Severe Atopic Dermatitis in Adolescent and Adult Patients from Portugal and Greece: Results from the Global Cross-Sectional Study MEASURE-AD

葡萄牙和希腊青少年及成年患者中中重度特应性皮炎的多维负担:全球横断面研究MEASURE-AD的结果

2025-04-260
OA
Psoriasis severity in moderate to severe psoriatic Greek patients routinely treated with systemic treatment: a cross-sectional and retrospective chart review study (CRYSTAL-Greece)

银屑病严重程度在常规接受系统性治疗的中重度银屑病希腊患者中的表现:一项横断面和回顾性病历审查研究(CRYSTAL-Greece)

2025-01-270
OA
Real-World Experience of Secukinumab Treatment in Patients with Moderate-to-Severe Plaque Psoriasis in Greece: 3-Year Interim Results of the SERENA Study
2024-09-180
OA
Real-world data on the effectiveness of brodalumab in patients with moderate-to severe plaque psoriasis in the Greek clinical setting (the BrIDGE study)
2024-02-031
PRE
Real world experience of brodalumab treatment in patients with moderate-to-severe plaque psoriasis in the Greek population: Results from an interim analysis of the BrIDGE study
2022-11-015
OA
A real-world, non-interventional, prospective study of the effectiveness and safety of apremilast in bio-naive adults with moderate plaque psoriasis treated in the routine care in Greece - the 'APRAISAL' study
2022-05-217
PRE
Effectiveness and safety of apremilast in biologic-naive patients with moderate psoriasis treated in routine clinical practice in Greece: the APRAISAL study
2021-07-135
PREAI